Envestnet Asset Management’s Abivax ABVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.44M Buy
63,354
+4,145
+7% +$469K ﹤0.01% 2053
2026
Q1
$6.59M Buy
59,209
+13,541
+30% +$1.6M ﹤0.01% 2122
2025
Q4
$6.16M Buy
45,668
+25,368
+125% +$2.77M ﹤0.01% 2034
2025
Q3
$1.72M Buy
+20,300
New +$1.24M ﹤0.01% 2978

Other funds holding ABVX

Envestnet Asset Management's ABVX Position: Q2 2026 in Review

Envestnet Asset Management increased its Abivax (ABVX) stake by 7% in Q2 2026, buying an estimated $469K and bringing the position to 63,354 shares worth $8.44M. The position accounts for ﹤0.01% of the portfolio, ranked #2053.

Envestnet Asset Management first reported a position in ABVX in Q3 2025 and has held it in 4 quarters since. 75 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Envestnet Asset Management held 63,354 shares of Abivax worth $8.44M as of Q2 2026.
  • Envestnet Asset Management bought 4,145 Abivax shares in Q2 2026, an estimated $469K.
  • Abivax made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #2053 holding.
  • Envestnet Asset Management first reported a position in Abivax in Q3 2025 and has held it in 4 quarters since.
  • 75 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.